UK markets open in 45 minutes

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.67-0.26 (-4.38%)
At close: 04:00PM EST
5.67 0.00 (0.00%)
After hours: 04:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 142.13M
Enterprise value 124.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.91
Price/book (mrq)8.86
Enterprise value/revenue 1.67
Enterprise value/EBITDA -4.49

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-61.29%
S&P500 52-week change 325.02%
52-week high 331.99
52-week low 35.21
50-day moving average 37.33
200-day moving average 312.36

Share statistics

Avg vol (3-month) 363.88k
Avg vol (10-day) 3102.03k
Shares outstanding 527.02M
Implied shares outstanding 6N/A
Float 87.36M
% held by insiders 172.19%
% held by institutions 115.81%
Shares short (14 Nov 2021) 4477.14k
Short ratio (14 Nov 2021) 413.03
Short % of float (14 Nov 2021) 43.68%
Short % of shares outstanding (14 Nov 2021) 41.77%
Shares short (prior month 14 Oct 2021) 4488.55k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin -46.31%
Operating margin (ttm)-40.95%

Management effectiveness

Return on assets (ttm)-27.86%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)74.31M
Revenue per share (ttm)2.94
Quarterly revenue growth (yoy)-29.00%
Gross profit (ttm)23.56M
EBITDA -27.38M
Net income avi to common (ttm)-34.41M
Diluted EPS (ttm)-1.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)47.91M
Total cash per share (mrq)1.77
Total debt (mrq)30M
Total debt/equity (mrq)187.08
Current ratio (mrq)2.48
Book value per share (mrq)0.59

Cash flow statement

Operating cash flow (ttm)-26.78M
Levered free cash flow (ttm)-10.09M